Abstract:If one reviews the literature with zeal, it is increasingly apparent that few organs escape recruitment when IBD is chronic or progressive. Insights into mucosal pathophysiology have helped with understanding the more frequent extraintestinal manifestations, but the mechanisms attendant to the development of less common events (e.g. acute pancreatitis, concurrent gluten sensitive enteropathy, or active pulmonary disease) remain either poorly studied or obscure. It is particularly interesting, however, to read reports of abnormal pulmonary function, generally of the obstructive type, correlated to measurements of abnormal intestinal permeability in patients with either active pulmonary sarcoid or pulmonary involvement in Crohn's disease. It has been further speculated that similarities in the mucosal immune system of the lung and intestine are responsible for evidence of bronchial hyperreactivity in patients with active IBD. Finally, it is important to recognize that extensions of the inflammatory process are not restricted to the development of organ-based events but may be responsible for some of the most frequent systemic abnormalities detected in IBD patients. It is now also well confirmed that the cytokine environment in IBD can support activated coagulation and, in some clinical situations, overt vascular thrombosis. The cerebrovascular complications of IBD are well recognized and range from peripheral venous thrombosis to central stroke syndromes and pseudotumor cerebri. Reports of focal white matter lesions in the brains of patients with IBD or an increased incidence of polyneuropathy may be other clinical examples of regional microvascular clotting. Microvascular injury appears to be more ubiquitously present, with reports ranging from a speculated primary causative role (e.g., granulomatous vasculitis in the mesenteric circulation) to the utility of nailbed vasospasm, in Crohn's disease, as a clinical marker for disease activity. It is also reported that IL-6 suppression of erythropoietin production is a major feature of the chronic anemia seen in active IBD. Moreover, the capacity of peripheral monocytes from active IBD patients to secrete TNF and IL-8 is reported predictive for the degree of therapeutic response from recombinant erythropoietin. These collected observations constitute another excellent example of the symmetry between basic science and clinical utility. It is from the context of applied basic science that many future therapies will arise. Empiricism will lose much of its appeal as clinical observations will be increasingly translated into cellular language. Already in animal models, elemental diets diminish IL-6-related acute inflammatory injury, and reductions in dietary lipid alter the antigenicity of bacteria. Provocatively, in humans, unconfirmed reports have even associated diet therapy with the resolution of uveitis and pyoderma gangrenosum. It is likely that efforts will also be made to induce oral tolerance if specific triggering proteins are discovered or to alter bowel flora if such an arcane area of investigation becomes resurgent.

S3889 Unexplained Dyspnea: A Rare Case of Crohn's Disease Complicated with Bronchiolitis Obliterans

Characteristics and Prognosis of Isolated Small-Bowel Crohn’s Disease

Respiratory Involvement in Children with Inflammatory Bowel Disease

Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections

Is the Identification of Caseating Granuloma in the Intestine Indicative of Tuberculosis? a Rare Case of Crohn’s Disease

Imaging findings of thoracic manifestations of Crohn's disease and ulcerative colitis

Necrobiotic Pulmonary Nodules in Ulcerative Colitis: A Rare Case Report

Differences in Lung Dysfunction between Inflammatory Bowel Disease and Ir-ritable Bowel Syndrome Based on Interaction of Lung and Large Intestine

P1119 Increased risk of chronic respiratory disease among individuals with Inflammatory Bowel Disease in a prospective cohort study

Eosinophilic pulmonary disease with ulcerative colitis: A case report

Differentiating Crohnʼs Disease from Intestinal Tuberculosis Using an Interferon Gamma Release Assay

FREE AIR FROM WHERE? SPONTANEOUS PNEUMOMEDIASTINUM AND SUBCUTANEOUS EMPHYSEMA IN A PATIENT WITH ULCERATIVE COLITIS IN THE ABSENCE OF COLONIC OR ESOPHAGEAL PERFORATION

Pulmonary Cryptococcosis after Immunomodulator Treatment in Patients with Crohn's Disease: Three Case Reports.

Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease

Primary Sclerosing Cholangitis and Crohn's Disease: A Rare Association

Induced sputum eosinophilia in ulcerative colitis patients: The lung as a mirror image of intestine?

Lung abscess in a non-compliant patient with Crohn�s disease

Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn's disease and intestinal tuberculosis

Extraintestinal considerations in inflammatory bowel disease

A Rare Case of Bronchial Anthracofibrosis with Pleural Anthracosis Presented as Recurrent Pleural Effusion

Clinical manifestations of connective tissue diseases complicated with interstitial lung disease:an analysis of 90 cases